Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2025-06-09 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Statement of Changes in Beneficial Ownership 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission (SEC), which reports changes in beneficial ownership of company securities by insiders such as directors or officers. It details a transaction by Peter C. Farrell, a director of ResMed Inc, involving the disposal of shares. Form 4 filings are specifically used to report insider transactions and are not financial reports, earnings releases, or other types of filings. Therefore, this document fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual Form 4 filing, not an announcement or certification.
2025-06-09 English
Notice of Proposed Sale of Securities 3 pages 464.8KB
Regulatory Filings Classification · 90% confidence The document contains only references to omitted pictures and no textual content or substantive information. It is extremely short (275 characters) and does not contain any financial data, regulatory references, or report content. Given the lack of content, it cannot be classified as a report or detailed filing. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without clear classification.
2025-06-09 English
Notice of Proposed Sale of Securities 3 pages 139.7KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details the sale of securities by an insider (a director) including dates, amounts, and broker information. This type of filing is specifically related to insider transactions and proposed sales of securities by company insiders, not a financial report, earnings release, or management discussion. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. The closest fitting category is Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length and content confirm it is a full Form 144 filing, not just an announcement or certification. Therefore, the correct classification is DIRS with high confidence.
2025-06-05 English
Notice of Proposed Sale of Securities 3 pages 139.4KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details the sale of securities by an insider or affiliate, including information about the filer, issuer, securities to be sold, dates, amounts, and broker information. This type of filing is specifically related to insider transactions and personal share dealings by company directors or executives. It is not a financial report, earnings release, or regulatory announcement unrelated to insider transactions. Therefore, the correct classification is Director's Dealing (DIRS). The document length and content fully support this classification with high confidence.
2025-06-03 English
Notice of Proposed Sale of Securities 3 pages 136.0KB
Regulatory Filings Classification · 100% confidence The document is a Form 144 filing, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It contains detailed information about the filer, the securities to be sold, acquisition details, and sales in the past 3 months. This form is used to notify the SEC and the public about insider or affiliate sales of restricted or control securities. It is not an annual report, earnings release, or any other financial report but a regulatory filing related to insider transactions. Therefore, it fits best under the category of Regulatory Filings (RNS).
2025-06-03 English
Statement of Changes in Beneficial Ownership 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission, which reports changes in beneficial ownership of company securities by insiders such as officers or directors. It includes details of a transaction by Brett Sandercock, Chief Financial Officer of ResMed Inc., indicating a sale of shares. Form 4 filings are specifically used to disclose insider transactions and are not financial reports, earnings releases, or management information. Therefore, this document fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual filing, not just an announcement or certification.
2025-06-03 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.